跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
PRIVA-ROSUVASTATIN - Health Canada Drug Approval Details
Approvals
/
Health Canada
/
PRIVA-ROSUVASTATIN
Authorized
STANDARD
PRIVA-ROSUVASTATIN
pharmapar inc
🇨🇦 Health Canada
Approval Date
Jul 4, 2025
Approval ID
a7d7b1dae9aa1972
Company
pharmapar inc
Type
Standard
Approval Details
Approval Id
a7d7b1dae9aa1972
Drug Approval Canada Name
PRIVA-ROSUVASTATIN
Product Name
PRIVA-ROSUVASTATIN
Status
Cancelled Post Market
Status Date
2022-09-27
Original Market Date
2016-06-29
Din
02445417
Drug Class
Human
Dosage Form
Tablet
Route Of Administration
Oral
Schedule
Prescription
Ahfs
24:06.08
Atc Original
C10AA07 ROSUVASTATIN
Atc Name
c 10 aa 07
Aig Number
0148963004
Company Name
pharmapar inc
Company Address
1565 Boul Lionel-Boulet, Varennes, Quebec, Canada, J3X 1P7
Active Ingredients
ROSUVASTATIN (ROSUVASTATIN CALCIUM)
5 MG
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Jul 4, 2025
Approval ID
a7d7b1dae9aa1972
Type
Standard
Back to Health Canada Approvals